Skip to content
Open access

Mapping genetic convergence across brain structure, mental health, and cardiometabolic disease

Jul 2026 · Communications Medicine · Vol 6 · 0 citations · 109 references
Medicine

TL;DR

It is found that schizophrenia and ADHD show distinct genetic patterns: schizophrenia shares more genetic factors with brain structure and diabetes, while ADHD is more strongly linked to metabolic pathways.

Abstract

Individuals with psychiatric disorders frequently experience comorbid cardiometabolic conditions, complicating treatment and worsening health outcomes. Both psychiatric and cardiometabolic disorders have been individually associated with alterations in brain structure. Yet, it remains unclear whether these associations stem from a shared genetic basis that underlies their frequent co-occurrence. We analyzed genome-wide association summary statistics from large international consortia of individuals of European ancestry, including psychiatric disorder GWAS with case–control sample sizes ranging from ~18,000 to ~158,000 cases, cardiometabolic disease GWAS with up to ~242,000 cases, and cortical morphology GWAS from UK Biobank comprising ~39,000 individuals. We applied complementary multivariate, causal, and mediation genetic analyses to disentangle genetic factors underlying brain alterations and comorbidity. Here we show that patterns of genetic overlap differ across disorders. Schizophrenia exhibits substantial polygenic overlap with cortical thickness and type 2 diabetes, despite low genetic correlation. In contrast, attention-deficit/hyperactivity disorder (ADHD) is more strongly correlated with cardiometabolic disease but shows limited overlap with cortical morphology. Notably, cortical surface area partly mediates the genetic association between ADHD and type 2 diabetes. Pathway analyses highlight metabolic stress processes in ADHD as well as neurodevelopmental and immune processes in schizophrenia. These findings indicate that psychiatric–cardiometabolic comorbidity arises through both shared and disorder-specific genetic pathways. This work clarifies the genetic architecture of multimorbidity and highlights opportunities for trait-targeted prevention strategies in psychiatry. Kopal et al. integrate large-scale genetic data to map the shared architecture across psychiatric disorders, cardiometabolic disease, and brain morphology. Their findings reveal divergent patterns: schizophrenia shows extensive overlap with cortical thickness and type 2 diabetes, whereas ADHD displays a metabolic-linked profile. Many people with psychiatric disorders also experience physical health problems, such as heart disease or diabetes. It remains unclear whether these links are due to shared genetic factors. In this study, we used large genetic datasets from hundreds of thousands of participants to investigate how psychiatric disorders, brain structure, and cardiometabolic diseases are genetically connected. We applied statistical methods to identify shared genetic influences and to explore whether one trait may partly influence another. We found that schizophrenia and ADHD show distinct genetic patterns: schizophrenia shares more genetic factors with brain structure and diabetes, while ADHD is more strongly linked to metabolic pathways. These findings highlight that different mental disorders may involve different biological routes, which could inform prevention and treatment strategies in the future.

Read PDF

Similar papers

Open access Jul 2026

Shared genetic architecture between schizophrenia and subcortical brain susceptibility phenotypes.

The shared genetic architecture between SCZ and subcortical brain susceptibility phenotypes is dissected by integrating large-scale genome-wide association study data with quantitative susceptibility mapping (QSM) phenotypes across 16 subcortical regions, highlighting pathways that may offer novel therapeutic strategies for SCZ and related brain susceptibility-associated conditions.

Yingying Xie, Jiaojiao Du, Yao Zhao et al. · 0 citations
Open access Jul 2026

The genetic relationship between ADHD and shortened telomeres points to neurodevelopmental mechanisms.

Attention-Deficit/Hyperactivity Disorder (ADHD) is often accompanied by other psychiatric and somatic conditions. Telomere shortening as an accelerated biological aging marker may underlie this aggregate burden. Telomere length (TL) has previously been associated with childhood inattention and hyperactivity, as well as other neuropsychiatric conditions. We hypothesize that TL and ADHD may share overlapping genetic influences, suggesting that some of the same genes could affect both cellular aging and ADHD traits. We investigated the pleiotropic and causal associations between these traits. Using the latest and largest publicly available genome-wide association study (GWAS) summary data for ADHD (38,691 cases and 186,843 controls) and TL (472,174 subjects), we tested causality, global and local genetic correlations, and joint genomic effects. Polygenic scores (PGS) were evaluated in an independent clinical sample of 665 ADHD cases and 995 controls, and TL was quantified via qPCR in a subsample of 370 subjects. The pleiotropy analysis showed global and local (a chromosome 17 locus) negative correlations. Shared genomic analysis showed loci enriched across several chromosomes, notably including the same chromosome 17 locus. This locus contains a diverse set of genes involved in many biological pathways impacting core cellular functions, tissue development, cell cycle, and apoptosis. Mendelian randomization indicated a unidirectional causal effect of ADHD on shorter TL across four methods. In our independent clinical sample, TL was shorter in individuals with ADHD. Lastly, higher PGS for longer TL was associated with reduced ADHD symptomatology. Our findings suggest that ADHD may contribute to TL, and genetic predisposition to shorter TL is associated with greater ADHD severity.

M. Tavares, E. Grevet, J. Schuch et al. · 0 citations
Open access Jul 2026

Transcriptomic signatures of early- versus late-diagnosed ADHD and implications for treatment heterogeneity.

A transcriptome-wide association study to dissect ADHD subtypes by age at first diagnosis offers a bridge between statistical genetic associations and biologically interpretable pathways relevant to clinical heterogeneity and provides a functional explanation for previously reported genetic and comorbidity differences by age at diagnosis.

Cheung Ngo · 0 citations
Open access Jul 2026

A Genetic Atlas of Direct and Inverse Neuropsychiatric-Cancer Comorbidity

Direct and inverse comorbidities between neuropsychiatric disorders and cancer are increasingly recognised as important features of the nervous system–cancer relationship, yet the inherited genetic architecture underlying these patterns remains poorly understood. Here, we analysed pairwise genetic correlations across 35 diseases represented by 115 GWAS datasets, including 9 psychiatric disorders, 10 neurological diseases and 16 cancers, using linkage disequilibrium score regression (LDSC) and high-definition likelihood (HDL), complemented by meta-analysis, subtype-resolved analyses, local covariance mapping and multi-omic benchmarking. Genetic correlations were predominantly positive and strongest within disease categories, whereas cancer–neurological pairs showed the weakest overall genetic affinity. Meta-analysis and subtype resolution uncovered associations obscured in aggregate analyses, including opposing correlations between familial and late-onset Alzheimer’s disease and lung cancer, revealing subtype-dependent neuro-oncological biology. Local analyses identified recurrent genomic loci where direct comorbidities are consistent with shared inflammatory, interferon, survival and tissue-remodelling programs, whereas inverse comorbidities suggest competing demands on apoptotic regulation, immune tone and stress-response calibration between neuronal and tumour-cell states. Together, these findings provide a genome-scale genetic framework for neuropsychiatric–cancer comorbidity and identify shared inherited biological programs as candidates for mechanistic investigation and therapeutic translation.

María Flores-Rodero, Jaume Forés Martos, Joan Vicent Sánchez Ortí et al. · 0 citations
Open access Aug 2026

Rare variation illuminates the distinct and pleiotropic genetic architecture of autism across neuropsychiatric traits

This study finds that rare variants across hundreds of genes contribute to autism with variable phenotypic outcomes, and clusters them based on association evidence from large-scale studies of developmental disorders, schizophrenia, bipolar disorder, and epilepsy.

F. Satterstrom, C. Auwerx, J. Fu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.